{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:20:46Z","timestamp":1783999246970,"version":"3.55.0"},"reference-count":43,"publisher":"Medwave Estudios Limitada","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2020.02.7831","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T20:39:31Z","timestamp":1586205571000},"page":"e7831-e7831","source":"Crossref","is-referenced-by-count":6,"title":["Different approaches in the management of macular hemorrhage: Case reports and a literature review"],"prefix":"10.5867","volume":"20","author":[{"given":"Jaime Leonel","family":"Quiroz-Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Alejandro","family":"Valera-Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon","family":"Garc\u00eda-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ram\u00edrez-Neria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Villalpando-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Romero-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Garc\u00eda-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3888","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Bopp S, Mirshahi A. Management of Macular Hemorrhage. Springer. 2018. Classification of Macular Hemorrhages;11-21. | CrossRef |","DOI":"10.1007\/978-3-319-65877-3_3"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997 Nov-Dec;42(3):195-213. | CrossRef | PubMed |","DOI":"10.1016\/S0039-6257(97)00089-1"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kunavisarut P, Thithuan T, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, et al. Submacular Hemorrhage: Visual Outcomes and Prognostic Factors. Asia Pac J Ophthalmol (Phila). 2018 Mar-Apr;7(2):109-113. | CrossRef | PubMed |","DOI":"10.4274\/tjo.galenos.2021.09258"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, et al. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1153-7. | CrossRef | PubMed |","DOI":"10.1007\/s00417-011-1649-1"},{"key":"ref4","unstructured":"Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration]. J Fr Ophtalmol. 2010 Feb;33(2):84-91. | CrossRef | PubMed |"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Lee JP, Park JS, Kwon OW, You YS, Kim SH. Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas. Korean J Ophthalmol. 2016 Jun;30(3):192-7. | CrossRef | PubMed |","DOI":"10.3341\/kjo.2016.30.3.192"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Johnson MW. Pneumatic displacement of submacular hemorrhage. Curr Opin Ophthalmol. 2000 Jun;11(3):201-6. | CrossRef | PubMed |","DOI":"10.1097\/00055735-200006000-00009"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Durukan AH, Kerimoglu H, Erdurman C, Demirel A, Karagul S. Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. Eye (Lond). 2008 Feb;22(2):214-8. | CrossRef | PubMed |","DOI":"10.1038\/sj.eye.6702574"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Li N, Zhu Z, Yi G, Li S, Han X. Valsalva Retinopathy in Twin-Pregnancy: A Case Report and Literature Review. Am J Case Rep. 2018 Jan 2;19:5-9. | CrossRef | PubMed |","DOI":"10.12659\/AJCR.905738"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Kuhn F, Morris R, Witherspoon CD, Mester V. Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology. 1998 Mar;105(3):472-7. | CrossRef | PubMed |","DOI":"10.1016\/S0161-6420(98)93030-5"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"De Maeyer K, Van Ginderdeuren R, Postelmans L, Stalmans P, Van Calster J. Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy. Br J Ophthalmol. 2007 Jul;91(7):869-72. | CrossRef | PubMed |","DOI":"10.1136\/bjo.2006.109132"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Garc\u00eda Fern\u00e1ndez M, Navarro JC, Casta\u00f1o CG. Long-term evolution of Valsalva retinopathy: a case series. J Med Case Rep. 2012 Oct 10;6:346. | CrossRef | PubMed |","DOI":"10.1186\/1752-1947-6-346"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Mennel S. Subhyaloidal and macular haemorrhage: localisation and treatment strategies. Br J Ophthalmol. 2007 Jul;91(7):850-2. | CrossRef | PubMed |","DOI":"10.1136\/bjo.2007.114025"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Aumiller MS, Rinehart J. Multi-layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review. Clin Exp Optom. 2015 Mar;98(2):117-21. | CrossRef | PubMed |","DOI":"10.1111\/cxo.12215"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Goldenberg D, Soiberman U, Loewenstein A, Goldstein M. Heidelberg spectral-domain optical coherence tomographic findings in retinal artery macroaneurysm. Retina. 2012 May;32(5):990-5. | CrossRef | PubMed |","DOI":"10.1097\/IAE.0b013e318229b233"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991 May;109(5):723-9. | CrossRef | PubMed |","DOI":"10.1001\/archopht.1991.01080050139046"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology. 2004 Nov;111(11):1967-80. | CrossRef | PubMed |","DOI":"10.1016\/j.ophtha.2004.07.021"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Shin JY, Lee JM, Byeon SH. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage. Am J Ophthalmol. 2015 May;159(5):904-14.e1. | CrossRef | PubMed |","DOI":"10.1016\/j.ajo.2015.01.024"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Stanescu-Segall D, Balta F, Jackson TL. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature. Surv Ophthalmol. 2016 Jan-Feb;61(1):18-32. | CrossRef | PubMed |","DOI":"10.1016\/j.survophthal.2015.04.004"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014 Nov;132(11):1334-40. | CrossRef | PubMed |","DOI":"10.1001\/jamaophthalmol.2014.2854"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Ophthalmology. 2004 Jun;111(6):1201-8. | CrossRef | PubMed |","DOI":"10.1016\/j.ophtha.2003.10.020"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001 Feb;131(2):208-15. | CrossRef | PubMed |","DOI":"10.1016\/S0002-9394(00)00734-0"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996 Mar;121(3):267-75. | CrossRef | PubMed |","DOI":"10.1016\/S0002-9394(14)70274-0"},{"key":"ref23","unstructured":"Thompson JT, Sjaarda RN. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage\/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement. Trans Am Ophthalmol Soc. 2005;103:98-107; discussion 107. | PubMed |"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Scheider A, G\u00fcndisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefes Arch Clin Exp Ophthalmol. 1999 Jan;237(1):10-5. | CrossRef | PubMed |","DOI":"10.1007\/s004170050187"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol. 2007 Dec;144(6):886-892. | CrossRef | PubMed |","DOI":"10.1016\/j.ajo.2007.07.034"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Shienbaum G, Garcia Filho CA, Flynn HW Jr, Nunes RP, Smiddy WE, Rosenfeld PJ. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol. 2013 Jun;155(6):1009-13. | CrossRef | PubMed |","DOI":"10.1016\/j.ajo.2013.01.012"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, et al. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage. Acta Ophthalmol. 2013 May;91(3):274-8. | CrossRef | PubMed |","DOI":"10.1111\/j.1755-3768.2011.02264.x"},{"key":"ref28","unstructured":"Nourinia R, Bonyadi MH, Ahmadieh H. Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration. J Ophthalmic Vis Res. 2010 Jul;5(3):168-74. | PubMed |"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Arias L, Mon\u00e9s J. Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. Clin Ophthalmol. 2010 Feb 18;4:67-72. | CrossRef | PubMed |","DOI":"10.2147\/OPTH.S8635"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"van Zeeburg EJ, van Meurs JC. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration. Ophthalmologica. 2013;229(1):1-14. | CrossRef | PubMed |","DOI":"10.1159\/000343066"},{"key":"ref31","unstructured":"Chen YY, Lin LY, Chang PY, Chen FT, Mai ELC, Wang JK. Laser and Anti-Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysm. Asia Pac J Ophthalmol (Phila). 2017 Sep-Oct;6(5):444-449. | CrossRef | PubMed |"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Zweifel SA, T\u00f6nz MS, Pfenninger L, Becker M, Michels S. Intravitreal anti-VEGF therapy for retinal macroaneurysm. Klin Monbl Augenheilkd. 2013 Apr;230(4):392-5. | CrossRef | PubMed |","DOI":"10.1055\/s-0032-1328377"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Tsakpinis D, Nasr MB, Tranos P, Krassas N, Giannopoulos T, Symeonidis C, et al. The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report. Clin Ophthalmol. 2011;5:1475-7. | CrossRef | PubMed |","DOI":"10.2147\/OPTH.S23535"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Cakir M, Ceki\u00e7 O, Yilmaz OF. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator. Eur J Ophthalmol. 2010 May-Jun;20(3):565-71. | PubMed |","DOI":"10.1177\/112067211002000305"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Abdelkader E, Yip KP, Cornish KS. Pneumatic displacement of submacular haemorrhage. Saudi J Ophthalmol. 2016 Oct-Dec;30(4):221-226. | CrossRef | PubMed |","DOI":"10.1016\/j.sjopt.2016.10.002"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN. Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology. 2003 Apr;110(4):704-8. | CrossRef | PubMed |","DOI":"10.1016\/S0161-6420(02)01979-6"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999 Apr;237(4):273-7. | CrossRef | PubMed |","DOI":"10.1007\/s004170050232"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol. 1995 Jan;113(1):62-9. | CrossRef | PubMed |","DOI":"10.1001\/archopht.1995.01100010064022"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999 Oct;106(10):1900-6; discussion 1906-7. | CrossRef | PubMed |","DOI":"10.1016\/S0161-6420(99)90399-8"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology. 2004 Nov;111(11):1993-2006. | CrossRef | PubMed |","DOI":"10.1016\/j.ophtha.2004.07.023"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Ahmad S, Bearelly S, Stinnett SS, Cooney MJ, Fekrat S. Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration. Am J Ophthalmol. 2008 Jun;145(6):1052-1057. | CrossRef | PubMed |","DOI":"10.1016\/j.ajo.2008.02.008"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK,et al. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol. 2004 Feb;88(2):186-90. | CrossRef | PubMed |","DOI":"10.1136\/bjo.2003.019273"}],"container-title":["Medwave"],"original-title":["Diferentes abordajes en el manejo de las hemorragias maculares: reporte de casos y revisi\u00f3n de literatura"],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T19:27:48Z","timestamp":1666294068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/Estudios\/Casos\/7831.act"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":43,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2020,3,31]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2020.02.7831","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}